REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent
NCT00631540 is an interventional trial sponsored by Cook Group Incorporated. As of 21 Nov 2026, it is completed. It studies Renal Artery Stenosis. The registry lists an enrollment of 100 participants at 7 sites in 1 country. The registry lists a start date of 29 Feb 2008 and a primary completion date of 31 May 2010.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00631540 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Cook Group Incorporated |
| Enrollment | 100 |
| Registered sites | 7 |
| Countries | 1 |
| Conditions | Renal Artery Stenosis |
| Start | 29 Feb 2008 |
| Primary completion | 31 May 2010 |
| Study completion | 31 May 2012 |
| Last update posted | 16 Dec 2013 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Robert Bersin, MD
Swedish Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Munroe Regional Medical Center
Ocala
- Orlando Regional Medical Center
Orlando
- Lenox Hill Hospital
New York
- Wake Med Raleigh Campus
Raleigh
- Fairfield Medical Center
Lancaster
- Pinnacle Health at Harrisburg
Harrisburg
- Swedish Medical Center
Seattle
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00631540
Each answer restates registry values shown on this page.
What is NCT00631540?
NCT00631540 is an interventional trial sponsored by Cook Group Incorporated. It studies Renal Artery Stenosis.
Who leads NCT00631540?
The registry names Robert Bersin, MD (principal investigator, Swedish Medical Center) as the overall official.
Where does NCT00631540 run?
The registry lists 7 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT00631540 end?
The registry lists a primary completion date of 31 May 2010 and a study completion date of 31 May 2012. The sponsor last updated the record on 16 Dec 2013.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.